Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Nov;50(1):314-315.
doi: 10.1038/s41386-024-01929-9.

Transcranial photobiomodulation: an emerging therapeutic method to enhance brain bioenergetics

Naomi L Gaggi  1 , Dan V Iosifescu  2   3
Affiliations

Transcranial photobiomodulation: an emerging therapeutic method to enhance brain bioenergetics

Naomi L Gaggi et al. Neuropsychopharmacology. 2024 Nov.

Erratum in

No abstract available

PubMed Disclaimer

Conflict of interest statement

In the last 10 years, D.V.I. has served as a consultant for Alkermes, Allergan, Angelini, Autobahn, Axsome, Biogen, Boehringer Ingelheim, the Centers for Psychiatric Excellence, Clexio, Delix, Jazz, Lundbeck, Neumora, Otsuka, Precision Neuroscience, Relmada, Sage Therapeutics, and Sunovion. He has received grant support (paid to his institutions) from Alkermes, AstraZeneca, BrainsWay, LiteCure, NeoSync, Otsuka, Roche, and Shire. N.L.G. has no conflict of interests.

References

    1. Hamblin MR. Shining light on the head: Photobiomodulation for brain disorders. BBA Clin. 2016;6:113–24. 10.1016/j.bbacli.2016.09.002. - PMC - PubMed
    1. Cassano P, Petrie SR, Mischoulon D, Cusin C, Katnani H, Yeung A, et al. Transcranial photobiomodulation for the treatment of major depressive disorder. The ELATED-2 pilot trial. Photomed Laser Surg. 2018;36:634–46. 10.1089/pho.2018.4490. - PMC - PubMed
    1. Iosifescu DV, Norton RJ, Tural U, Mischoulon D, Collins K, McDonald E, et al. Very low-level transcranial photobiomodulation for major depressive disorder: The ELATED-3 multicenter, randomized, sham-controlled trial. J Clin Psychiatry. 2022;83:21m14226. 10.4088/JCP.21m14226. - PubMed
    1. Iosifescu DV, Collins KA, Hurtado-Puerto A, Irvin MK, Clancy JA, Sparpana A, et al. Grant report on the transcranial near infrared radiation and cerebral blood flow in depression (TRIADE) study. Photonics. 2023;10:90.
    1. Gaggi NL, Collins KA, Gonzalez-Castillo J, Hurtado AM, Castellanos FX, Osorio R, et al. Transcranial photobiomodulation increases intrinsic brain activity within irradiated areas in early Alzheimer’s disease: Potential link with cerebral metabolism. Brain Stimul. 2024;17:208–10. 10.1016/j.brs.2024.02.012. - PubMed

LinkOut - more resources